A novel subset of putative stem/progenitor CD34+ Oct-4 + cells is the major target for SARS coronavirus in human lung

41Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Identification of the nature of severe acute respiratory syndrome (SARS)-infected cells is crucial toward understanding the pathogenesis. Using multicolor colocalization techniques, we previously reported that SARS + cells in the lung of fatally infected patients expressed the only known functional receptor, angiotensin-converting enzyme 2, and also a binding receptor, liver/lymph node-specific ICAM-3-grabbing non-integrin (CD209L). In this study, we show that SARS-infected cells also express the stem/progenitor cell markers CD34 and Oct-4, and do not express cytokeratin or surfactant. These putative lung stem/progenitor cells can also be identified in some non-SARS individuals and can be infected by SARS-coronavirus ex vivo. Infection of these cells may contribute to the loss of lung repair capacity that leads to respiratory failure as clinically observed. JEM © The Rockefeller University Press.

Cite

CITATION STYLE

APA

Chen, Y., Chan, V. S. F., Zheng, B., Chan, K. Y. K., Xu, X., To, L. Y. F., … Lin, C. L. S. (2007). A novel subset of putative stem/progenitor CD34+ Oct-4 + cells is the major target for SARS coronavirus in human lung. Journal of Experimental Medicine, 204(11), 2529–2536. https://doi.org/10.1084/jem.20070462

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free